Welsh, Carson, Anderson & Stowe is now the majority stock holder of K2M, a spinal device company developing treatment for complex spinal pathologies, according to a company news release.
Under the agreement, K2M plans on growing its business to meet the demand for the company's product portfolio while expanding the company's worldwide sales force and accelerating research development of next generation technologies.
Read the release on the Welsh Carson acquisition of K2M.
Read more coverage about medical device acquisitions:
- Medtronic Acquires Osteotech for $123M, Expands Portfolio
- Baxter Acquires Orthobiologic Company Apa Tech
- Alphatech Acquires Scient'x Groupe
Under the agreement, K2M plans on growing its business to meet the demand for the company's product portfolio while expanding the company's worldwide sales force and accelerating research development of next generation technologies.
Read the release on the Welsh Carson acquisition of K2M.
Read more coverage about medical device acquisitions:
- Medtronic Acquires Osteotech for $123M, Expands Portfolio
- Baxter Acquires Orthobiologic Company Apa Tech
- Alphatech Acquires Scient'x Groupe